Results 131 to 140 of about 251,408 (329)
In Memoriam: W. King Engel, MD (1930–2025)
Annals of Neurology, EarlyView.
Marinos C. Dalakas, Steven P. Ringel
wiley +1 more source
Objective We evaluated serious infection risk in offspring exposed to tumor necrosis factor inhibitors (TNFi) in utero, separated by TNFi timing and placental transfer ability. Methods Using MarketScan (2011–2021), we identified offspring born to mothers with chronic inflammatory diseases.
Leah K. Flatman +6 more
wiley +1 more source
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.
J. S. San Miguel +20 more
semanticscholar +1 more source
One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults. [PDF]
An account is given of the 6- to 12-month survival, and causes of failure in 110 consecutive patients who underwent primary liver transplantation under treatment from the outset with FK 506 and steroids. The patient survival is 92.7%, and the first graft
Alessiani, M +9 more
core
Clinical Images: Subcutaneous panniculitis‐like T cell lymphoma
Arthritis &Rheumatology, EarlyView.
S Chambers, CN Myrdal, VP Werth
wiley +1 more source
Objective To evaluate the prognostic utility of circulating Interleukin‐18 (IL‐18) levels in predicting disease activity, macrophage activation syndrome (MAS), and disease course in Still's disease (SD) patients receiving first‐line IL‐1 inhibitors (IL‐1i).
Matteo Trevisan +8 more
wiley +1 more source
Se realizó un estudio prospectivo, aplicado y analítico para determinar la efectividad del tratamiento con altas dosis de dexametasona en pacientes con trombocitopenia inmune primaria crónica atendidos en la consulta de hemostasia del Instituto de ...
Wilfredo Roque-García +3 more
doaj
Objective To determine risk factors for relapse of ANCA‐associated vasculitis (AAV) after re‐induction of remission with rituximab and discontinuation of maintenance therapy. Methods This is a post‐hoc analysis of the RITAZAREM clinical trial. Patients 15 years or older with AAV and a positive test for anti‐proteinase‐3 (PR3‐) or anti‐myeloperoxidase ...
Ellen Romich +10 more
wiley +1 more source
Objective The multinational, phase 3, double‐blind, placebo‐controlled TULIP‐SC trial evaluated the efficacy and safety of subcutaneous anifrolumab in adults who have moderate‐to‐severe SLE activity, despite receiving standard therapy. Methods Adults with SLE received subcutaneous anifrolumab 120 mg or placebo once weekly for 52 weeks (1:1 ...
Susan Manzi +12 more
wiley +1 more source
La enfermedad de Still del adulto es una enfermedad inflamatoria sistémica de etología desconocida, de rara presentación; se caracteriza por fiebre alta, artritis, leucocitosis neutrofílica y exantema evanescente.
Jorge Luis León Álvarez +5 more
doaj

